GET THE APP

Fisheries and Aquaculture Journal

Fisheries and Aquaculture Journal
Open Access

ISSN: 2150-3508

+44 1478 350008

Perspective - (2022)Volume 13, Issue 4

Role of Vaccines in Control and Prevention of Infectious Disease in Aquaculture

Daniel Oliver*
 
*Correspondence: Dr. Daniel Oliver, Department of Fisheries, University of Melbourne, Melbourne, Australia, Email:

Author info »

Description

Aquaculture is a rapidly growing sector of the worldwide agricultural industry. It accounts for around 44% of total global fish output. Despite several hurdles in the aquaculture environment, this significant output growth has been achieved. Health limits must be addressed through scientifically validated and authorized techniques to reduce the impact of fish sickness. This analysis will highlight some of the most effective methods for preventing and controlling infectious illness in aquaculture. Vaccination is one of the most effective control measures available. Killer vaccines, attenuated vaccinations, DNA vaccines, recombinant technology vaccines, and synthetic peptide vaccines are some of the vaccines used in fish diseases. Vaccines can be administered to fish by oral, injectable, or immersion approaches. Despite their adverse effects on the development of medication resistance by bacteria, antibiotics are used in aquaculture. Probiotics, prebiotics, and medicinal plants are examples of biological and pharmacological disease control techniques.

Types of fish vaccines

Killed, attenuated, DNA, synthetic peptide, recombinant vector, genetically altered, and subunit vaccinations are all types of modern vaccines. Whole-organism vaccinations outperformed other forms of immunizations in this research. The majority of vaccinations, however, do not provide protection against disease. Killed vaccines are those that are made by killing the infectious pathogen and utilizing it as an antigen to stimulate an immune response. The majority of commercial aquaculture immunizations are fatal vaccines. These vaccines have the following advantages: They are simple to design, store well, are less costly, and have no pathogenicity concerns. The vaccine’s preparation method is to target the outer surface or interior portions of germs while preventing the capacity to multiply when injected into the host.

Attenuated vaccines are also traditional vaccinations that are used to prevent disease. They are made by subjecting organisms to numerous laboratory cycles, as well as physical and chemical attenuation, to reduce their virulence without killing them. In laboratory tests, live immunizations have been shown to be effective in fish. Mucosal, cellular, and humoral immunity are all induced by them. The weakened organism reproduces without causing any symptoms in the intended host.

DNA vaccines are a new form of vaccination that has emerged as a result of advances in molecular biology. Instead of using the antigen as a vaccination, molecular methods are used to extract the gene that codes for the antigen, which may then be administered as a vaccine. DNA vaccines include one or more pathogen genes. In farmed salmonids, intramuscular injection of these vaccinations provides rapid and long-lasting protection against diseases such as infectious hematopoietic necrosis virus and viral hemorrhagic septicemia virus, which were previously controlled by DNA vaccines.

Recombinant vector vaccines are the outcome of biotechnological progress that involves expressing just the pathogen's immunogenic areas in a heterologous host. Taken and expressed to carriers is the immunogenic component of the organism. The proteins are then purified and generated in high numbers in vitro for use as a vaccine. The ability to create vast numbers of proteins and the ability to properly express the antigenic protein are the two most important elements to consider when choosing a vector. To safeguard fish, infectious salmon anemia and infectious hematopoietic necrosis disease viruses have been expressed in vectors.

When cultivating an organism is challenging, the subunit vaccines are advantageous because they take the immunogenic component of the organism and use it as a vaccine. Subunit vaccines are safe to use, but their immunogenicity is far inferior to that of inactivated, whole-organism vaccinations. To enhance immunogenicity, adjuvants are required. Microorganisms can be genetically attenuated by molecular techniques that remove genes responsible for pathogenicity. A live attenuated vaccination can boost humoral and cellular immunity by replicating at a lower titer. These preparations can protect salmon against aeromonas salmonicida.

Synthetic peptide vaccines are made up of short sequences of amino acids that have been synthesized to function as antigens. These might be utilized as an antigenic site. Vaccinating fish using peptides is less feasible due to a lack of understanding of the fish immune response to various antigens and the fact that they are not powerful enough, necessitating the use of a carrier molecule, according to studies. Infectious diseases such as nodavirus, viral hemorrhagic septicemia, rhabdovirus, and birnavirus have all been treated using these vaccinations.

Conclusion

Aquaculture is a major and fast-growing booming sector. The sector has been confronted with several complex and diversified limits and obstacles. The majority of these issues are caused by infectious diseases, which cost billions of dollars each year. As a result, it is recommended that preventative and control measures be implemented based on globally accepted principles and locally acceptable solutions. Rather than treating diseased stocks, these tactics should concentrate on avoiding infection. In general, a combination of immunoprophylaxis, biosecurity measures, and the use of legally allowed antibiotics can provide the best health protection for farmed fish.

Author Info

Daniel Oliver*
 
Department of Fisheries, University of Melbourne, Melbourne, Australia
 

Citation: Oliver D (2022) Role of Vaccines in Control and Prevention of Infectious Disease in Aquaculture. Fish Aqua J. 13:300.

Received: 03-Jun-2022, Manuscript No. FAJ-22-17441; Editor assigned: 08-Jun-2022, Pre QC No. FAJ-22-17441 (PQ); Reviewed: 22-Jun-2022, QC No. FAJ-22-17441; Revised: 30-Jun-2022, Manuscript No. FAJ-22-17441 (R); Published: 07-Jul-2022 , DOI: 10.35248/2150-3508.22.13.300

Copyright: © 2022 Oliver D. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top